Telix Pharmaceuticals Limited Stock Analysis

TLX Stock   17.13  0.09  0.53%   
Telix Pharmaceuticals Limited is overvalued with Real Value of 12.85 and Hype Value of 17.13. The main objective of Telix Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Telix Pharmaceuticals Limited is worth, separate from its market price. There are two main types of Telix Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Telix Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Telix Pharmaceuticals is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Telix Stock trading window is adjusted to America/New York timezone.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Telix Stock Analysis Notes

The company had not issued any dividends in recent years. Telix Pharmaceuticals had 1:1000 split on the 29th of October 2013. To find out more about Telix Pharmaceuticals Limited contact the company at 61 3 9093 3855 or learn more at https://telixpharma.com.

Telix Pharmaceuticals Quarterly Total Revenue

7.41 Million

Telix Pharmaceuticals Investment Alerts

Telix Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Latest headline from finance.yahoo.com: Codan And 2 Other ASX Stocks That May Be Trading At A Discount

Telix Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Telix Pharmaceuticals' ESG score is a quantitative measure that evaluates Telix Pharmaceuticals' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Telix Pharmaceuticals' operations that may have significant financial implications and affect Telix Pharmaceuticals' stock price as well as guide investors towards more socially responsible investments.

Telix Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 5.23 B.

Telix Profitablity

The company has Net Profit Margin of 0.08 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.09 %, which entails that for every 100 dollars of revenue, it generated $0.09 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed 0.08  0.09 
Return On Assets 0.02  0.02 
Return On Equity 0.04  0.04 

Management Efficiency

Telix Pharmaceuticals has Return on Asset of 0.0797 % which means that on every $100 spent on assets, it made $0.0797 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2049 %, implying that it generated $0.2049 on every 100 dollars invested. Telix Pharmaceuticals' management efficiency ratios could be used to measure how well Telix Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.02 in 2025. Return On Capital Employed is likely to rise to 0.09 in 2025. At this time, Telix Pharmaceuticals' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 209.4 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 501 K in 2025.
Last ReportedProjected for Next Year
Book Value Per Share(0.25)(0.26)
Net Current Asset Value-10.3 M-10.9 M
Tangible Asset Value-3.2 M-3.3 M
Tangible Book Value Per Share(0.36)(0.37)
Enterprise Value Over EBITDA(5.30)(5.56)
Price Book Value Ratio(4.23)(4.44)
Enterprise Value Multiple(5.30)(5.56)
Price Fair Value(4.23)(4.44)
Enterprise ValueM8.6 M
The decision-making processes within Telix Pharmaceuticals are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin
0.0949
Profit Margin
0.0762
Beta
2.384
Return On Assets
0.0797
Return On Equity
0.2049

Technical Drivers

As of the 24th of January, Telix Pharmaceuticals has the Coefficient Of Variation of 921.53, risk adjusted performance of 0.0992, and Semi Deviation of 2.24. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telix Pharmaceuticals, as well as the relationship between them.

Telix Pharmaceuticals Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of thirty-four. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Telix Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Telix Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Telix Pharmaceuticals Predictive Daily Indicators

Telix Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Telix Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Telix Pharmaceuticals Forecast Models

Telix Pharmaceuticals' time-series forecasting models are one of many Telix Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telix Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Telix Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Telix Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telix Pharmaceuticals. By using and applying Telix Stock analysis, traders can create a robust methodology for identifying Telix entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.01  0.01 
Operating Profit Margin 0.04  0.04 
Net Profit Margin 0.01  0.01 
Gross Profit Margin 0.56  0.59 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Telix Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
All  Next Launch Module

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.